Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.450
+0.020 (4.63%)
At close: Dec 20, 2024, 4:00 PM
0.468
+0.018 (4.11%)
After-hours: Dec 20, 2024, 6:08 PM EST
Sensei Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -29.8 | -34.1 | -48.59 | -36.79 | -20.1 | -16.74 | |
| Depreciation & Amortization | 1.32 | 1.35 | 1.35 | 0.69 | 0.21 | 0.07 | |
| Loss (Gain) From Sale of Assets | - | 0.3 | -0.02 | -0.03 | - | - | |
| Loss (Gain) From Sale of Investments | -0.78 | -1.06 | 0.22 | 0.62 | - | - | |
| Stock-Based Compensation | 3.84 | 4.45 | 5.81 | 5.66 | 1.49 | 1.18 | |
| Other Operating Activities | 1.52 | 1.36 | 1.19 | -0.51 | 1.09 | 3.45 | |
| Change in Accounts Payable | -0.8 | -2.33 | 2.02 | -1.43 | 0.34 | 1.66 | |
| Change in Other Net Operating Assets | -0.34 | -2 | -1.01 | 1.54 | -0.73 | 1.81 | |
| Operating Cash Flow | -25.04 | -32.02 | -39.03 | -30.26 | -17.71 | -8.57 | |
| Capital Expenditures | -0.15 | -0.18 | -0.32 | -2.03 | -1.21 | -0.05 | |
| Sale of Property, Plant & Equipment | - | 0.17 | 0.02 | 0.32 | - | - | |
| Cash Acquisitions | - | - | - | - | -0.2 | - | |
| Investment in Securities | 34 | 38.43 | 50.26 | -141.41 | - | - | |
| Investing Cash Flow | 33.85 | 38.41 | 49.95 | -143.12 | -1.4 | -0.05 | |
| Short-Term Debt Issued | - | - | - | - | - | 3.75 | |
| Long-Term Debt Issued | - | - | - | - | 0.57 | 4.35 | |
| Total Debt Issued | - | - | - | - | 0.57 | 8.1 | |
| Long-Term Debt Repaid | - | -0.76 | -0.63 | -0.26 | -0.04 | -0.03 | |
| Net Debt Issued (Repaid) | -0.8 | -0.76 | -0.63 | -0.26 | 0.53 | 8.07 | |
| Issuance of Common Stock | 0.04 | 0.05 | 0.34 | 140.7 | 0.02 | 0.15 | |
| Repurchase of Common Stock | -0.26 | -10.46 | - | - | - | - | |
| Other Financing Activities | - | - | - | - | -2.11 | - | |
| Financing Cash Flow | -1.02 | -11.17 | -0.29 | 163.94 | 35.45 | 8.22 | |
| Net Cash Flow | 7.79 | -4.78 | 10.64 | -9.44 | 16.35 | -0.4 | |
| Free Cash Flow | -25.19 | -32.2 | -39.35 | -32.29 | -18.91 | -8.62 | |
| Free Cash Flow Per Share | -1.00 | -1.15 | -1.28 | -1.17 | -11.73 | -23.48 | |
| Levered Free Cash Flow | -15.5 | -21.32 | -22.49 | -17.56 | -16.35 | -3.92 | |
| Unlevered Free Cash Flow | -15.43 | -21.23 | -22.36 | -17.14 | -15.29 | -2.51 | |
| Change in Net Working Capital | 0.09 | 3.75 | -2.17 | -1.97 | 4.09 | -4.07 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.